Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 54 pages
Exam (elaborations)

NSG 527 MIDTERM EXAM 2026/2027 | Psychopathology & Advanced Clinical Modalities | Questions & Answers w/ Verified Rationales | Wilkes University | Pass Guaranteed - A+ Graded

Document preview thumbnail
Preview 4 out of 54 pages

Excel in the NSG 527 Midterm Exam at Wilkes University with the latest 2026/2027 questions and answers featuring verified rationales. This A+ Graded resource for the NSG 527 Psychopathology, Theories, and Advanced Clinical Modalities Midterm Assessment contains comprehensive exam-style questions with fully verified answers and detailed rationales covering all essential advanced practice concepts for the midterm evaluation. Featuring complete midterm coverage of foundational psychopathology across the lifespan, major theoretical frameworks, family systems theory, attachment theory, neurobiology of mental disorders, therapeutic communication techniques, cultural considerations in psychiatric care, and evidence-based practice foundations, it provides targeted preparation for this critical graduate-level nursing assessment. With questions reflecting actual Wilkes University NSG 527 midterm patterns, verified rationales explaining both correct and incorrect answers, alignment with latest 2026/2027 DSM-5-TR and PMHNP standards, and our Pass Guarantee, this is the definitive tool to demonstrate foundational psychiatric nursing competency, master core theoretical concepts, and pass your NSG 527 Midterm Exam on the first attempt. Download now and build your advanced clinical knowledge at Wilkes.

Content preview

NSG 527 MIDTERM EXAM 2026/2027 | Psychopathology &
Advanced Clinical Modalities | Questions & Answers w/
Verified Rationales | Wilkes University | Pass Guaranteed - A+
Graded


DOMAIN 1: Neurobiology Foundations

Q1: A 28-year-old patient with panic disorder is prescribed a benzodiazepine. The
PMHNP explains that this medication works primarily by enhancing which
neurotransmitter system?

A. Dopamine through blockade of D2 receptors in the mesolimbic pathway
B. Glutamate through antagonism at NMDA receptors to reduce excitatory signaling
C. GABA by potentiating its inhibitory effects at GABA-A receptors [CORRECT]
D. Serotonin through selective reuptake inhibition at the synaptic cleft

Correct Answer: C

Rationale: Benzodiazepines (e.g., lorazepam, clonazepam) exert their anxiolytic effects
primarily by binding to specific allosteric sites on GABA-A receptors, which enhances
the inhibitory effects of GABA (gamma-aminobutyric acid), the brain's primary inhibitory
neurotransmitter. This increases chloride ion influx into neurons, hyperpolarizing them
and reducing neuronal excitability—particularly beneficial for acute anxiety states.

Option A is incorrect because D2 receptor blockade is the mechanism of antipsychotics,
not anxiolytics. Option B describes the mechanism of NMDA antagonists like ketamine,
used for treatment-resistant depression, not panic disorder. Option D describes SSRIs,
which are first-line for long-term panic disorder management but work through a
different mechanism than benzodiazepines.

,NEURO PEARL: GABA is the most abundant inhibitory neurotransmitter in the CNS.
Approximately 40% of all synapses use GABA. Alcohol potentiates GABA-A receptors
similarly to benzodiazepines, which explains the cross-tolerance between alcohol and
benzodiazepines and the risk of respiratory depression when combined.



Q2: A patient with schizophrenia presents with prominent negative symptoms including
flat affect, alogia, and avolition. The PMHNP recognizes these symptoms correlate with
dysfunction in which dopaminergic pathway?

A. Mesolimbic pathway hyperactivity
B. Mesocortical pathway hypofunction [CORRECT]
C. Nigrostriatal pathway degeneration
D. Tuberoinfundibular pathway dysregulation

Correct Answer: B

Rationale: The mesocortical pathway projects from the ventral tegmental area (VTA) to
the prefrontal cortex and is critical for executive function, motivation, and emotional
expression. Hypofunction (reduced dopamine activity) in this pathway is strongly
associated with the negative symptoms of schizophrenia (flattened affect, alogia,
avolition, anhedonia, asociality) and cognitive deficits. This contrasts with the
mesolimbic pathway, where hyperactivity (Option A) produces positive symptoms
(hallucinations, delusions).

Option C (nigrostriatal pathway) involves dopamine projections to the basal ganglia;
degeneration causes Parkinson's disease or antipsychotic-induced extrapyramidal
symptoms (EPS). Option D (tuberoinfundibular pathway) regulates prolactin secretion;
blockade causes hyperprolactinemia.

NEURO PEARL: The "dopamine hypothesis" of schizophrenia has evolved: positive
symptoms = mesolimbic hyperactivity; negative/cognitive symptoms = mesocortical

,hypofunction. Second-generation antipsychotics attempt to address both by modulating
dopamine and serotonin receptors.



Q3: A 45-year-old veteran with PTSD shows reduced hippocampal volume on
neuroimaging. The PMHNP understands this structural change is most associated with
which clinical manifestation?

A. Impaired fear processing and hyperactive startle response
B. Deficits in explicit memory formation and contextual fear discrimination [CORRECT]
C. Loss of executive function and impaired judgment
D. Disruption of sensory relay and integration of stimuli

Correct Answer: B

Rationale: The hippocampus, located in the medial temporal lobe, is essential for
explicit (declarative) memory formation—the conscious recall of facts and events—and
for providing contextual information that helps distinguish safe from threatening
environments. In PTSD, chronic stress elevates cortisol, which is neurotoxic to
hippocampal neurons, leading to volume reduction. This explains why PTSD patients
often have fragmented trauma memories (poor contextual encoding) and difficulty
discriminating between safe and dangerous contexts (generalized fear responses).

Option A describes amygdala hyperfunction, not hippocampal deficits. Option C reflects
prefrontal cortex dysfunction. Option D describes thalamic function.

NEURO PEARL: The hippocampus is one of the few brain regions capable of
neurogenesis (new neuron formation) throughout adulthood. This has therapeutic
implications: aerobic exercise, antidepressants, and ECT may promote hippocampal
neurogenesis, potentially reversing stress-induced volume loss.

, Q4: During a neurobiology lecture, the PMHNP explains that the "all-or-none principle" of
action potentials refers to which phenomenon?

A. Once threshold is reached, an action potential fires with maximum amplitude
regardless of stimulus strength [CORRECT]
B. Neurons can only fire action potentials in response to excitatory neurotransmitters
C. All neurons in a circuit must fire simultaneously for signal transmission
D. Action potentials can only travel in one direction along the axon

Correct Answer: A

Rationale: The all-or-none principle states that when a neuron is depolarized to
threshold potential (approximately -55mV), voltage-gated sodium channels open rapidly,
causing a massive influx of Na+ ions. This triggers a full action potential of consistent
amplitude and duration (~100mV peak) regardless of whether the stimulus was barely
at threshold or significantly suprathreshold. The action potential does not "scale" with
stimulus intensity; instead, frequency of firing encodes stimulus strength.

Option B is incorrect because action potentials can be triggered by various stimuli
(electrical, chemical, mechanical). Option C is incorrect—neurons fire independently.
Option D describes unidirectional propagation due to refractory periods, not the
all-or-none principle.

NEURO PEARL: The all-or-none principle is fundamental to neural coding. Information is
encoded not in action potential amplitude (which is constant) but in firing frequency and
pattern. This digital-like signaling allows reliable long-distance communication in the
nervous system.



Q5: A PMHNP is prescribing lithium for bipolar disorder and considers that this
medication must cross which physiological barrier to reach its CNS targets?

A. The blood-cerebrospinal fluid barrier at the choroid plexus only

Document information

Uploaded on
February 28, 2026
Number of pages
54
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers
$16.50

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
BESTSELLERSTUVIA01
3.7
(116)
Sold
615
Followers
260
Items
5398
Last sold
23 hours ago




Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions